TITLE

Pharma: Other News To Note

PUB. DATE
May 2013
SOURCE
BioWorld Today;5/13/2013, Vol. 24 Issue 91, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on alliances and agreements between pharmaceutical companies as of May 13, 2013 including Actavis Inc. of New Jersey and Warner Chilcott PLC of Ireland, Novartis Pharmaceuticals Corp. in New Jersey and Regeneron Pharmaceuticals Inc., ScinoPharm Taiwan Ltd of Taiwan and Coland Holdings Ltd of Hong Kong.
ACCESSION #
87593108

 

Related Articles

  • Pharma: Other News To Note.  // BioWorld Today;4/8/2013, Vol. 24 Issue 66, p7 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including an agreement for Actavis Inc. to be the exclusive marketer for an ointment generic, Covis Pharmaceuticals Inc.'s decision to distribute in the country and Pozen Inc.'s disclosure of results of a study.

  • Pharma: Other News To Note.  // BioWorld Today;4/26/2013, Vol. 24 Issue 80, p11 

    The article presents pharmaceutical industry news briefs as of April 2013 including the settlement agreement reached by Actavis Inc. with Shire company on the patent litigation for the generic Intuniv of Actavis, the clinical trial agreement of Perosphere Inc. and Daiichi Sankyo Co. Ltd. for the...

  • Actavis Earns Over-The-Top Q1. Investor's Business Daily // Investors Business Daily;5/1/2014, pA01 

    4 The specialty-drug maker's EPS rose 75% to $3.49. Sales rose $6.6 bil, up 40%. Both beat analysts. Actavis' ([STOCK[ACT]]) purchase of Warner Chilcott and sales of its generic version of

  • News Briefs.  // MondayMorning;10/7/2013, Vol. 21 Issue 36, p7 

    The article offers news briefs related to the pharmaceutical industry and medical research. Generic drug maker Actavis PLC has completed an 8.5 billion dollar acquisition of drugmaker Warner Chilcott PLC. A study conducted in Sweden by Lena Johansson published in the journal "BMJ Open" has found...

  • FeverAll.  // Drug Store News;1/30/2012, Vol. 34 Issue 2, p58 

    The article offers brief information on the FeverAll acetaminophen suppositories from Actavis Inc.

  • Update.  // Medical Marketing & Media;Feb2014, Vol. 49 Issue 2, p11 

    The article offers U.S. marketing news briefs as of February 2014 on various topics including president of Novartis's oncology division, pipeline drug and restructuring generic drugmaker Actavis PLC.

  • Actavis.  // Chain Drug Review;9/28/2015, Vol. 37 Issue 15, p144 

    The article profiles Actavis PLC, a pharmaceutical company based in Dublin, Ireland which is focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.

  • Allergan Adds To Aesthetics. Investor's Business Daily // Investors Business Daily;6/18/2015, pA01 

    9 The drugmaker formerly known as Actavis would buy biotech

  • Actavis.  // MMR;10/17/2011, Vol. 28 Issue 16, p74 

    The article offers information about Actavis Inc., a pharmaceutical company, and its five core values.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics